Trial Profile
The clinical experience with Graceptor in de novo renal transplant patients and retrospective study of pharmacokinetics.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 14 May 2016
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 28 Jan 2010 New trial record